Advanced glycation endproducts in food and their effects on health.

[1]  Ye Xu,et al.  Trientine reduces BACE1 activity and mitigates amyloidosis via the AGE/RAGE/NF-κB pathway in a transgenic mouse model of Alzheimer's disease. , 2013, Antioxidants & redox signaling.

[2]  A. Katz Noncommunicable Diseases: Global Health Priority or Market Opportunity? An Illustration of the World Health Organization at its Worst and at its Best , 2013, International journal of health services : planning, administration, evaluation.

[3]  V. Gökmen,et al.  Antiglycative effect of fruit and vegetable seed extracts: inhibition of AGE formation and carbonyl-trapping abilities. , 2013, Journal of the science of food and agriculture.

[4]  N. Kellow,et al.  Dietary advanced glycation end-product restriction for the attenuation of insulin resistance, oxidative stress and endothelial dysfunction: a systematic review , 2013, European Journal of Clinical Nutrition.

[5]  L. Nikitina-Zake,et al.  Identification of glyoxalase 1 polymorphisms associated with enzyme activity. , 2013, Gene.

[6]  M. Cooper,et al.  Targeting the AGE‐RAGE axis improves renal function in the context of a healthy diet low in advanced glycation end‐product content , 2013, Nephrology.

[7]  Adam J Rosenberg,et al.  Total synthesis of pentosidine. , 2012, Organic letters.

[8]  G. Striker,et al.  Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1 , 2012, Proceedings of the National Academy of Sciences.

[9]  M. Hellwig,et al.  1,2-dicarbonyl compounds in commonly consumed foods. , 2012, Journal of agricultural and food chemistry.

[10]  Zhongling Zhang,et al.  Advanced glycation end products and neurodegenerative diseases: Mechanisms and perspective , 2012, Journal of the Neurological Sciences.

[11]  Rendy Kartika,et al.  Exploring post-translational arginine modification using chemically synthesized methylglyoxal hydroimidazolones. , 2012, Journal of the American Chemical Society.

[12]  R. Fernandes,et al.  Methylglyoxal promotes oxidative stress and endothelial dysfunction. , 2012, Pharmacological research.

[13]  Paul J Thornalley,et al.  Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation. , 2012, The Biochemical journal.

[14]  Paul J Thornalley,et al.  Methylglyoxal, glyoxalase 1 and the dicarbonyl proteome , 2012, Amino Acids.

[15]  L. Dragsted,et al.  Convenient Synthesis of Nε-(Carboxymethyl)lysine,a Key Advanced Glycation Endproduct Biomarker , 2012 .

[16]  J. Woodside,et al.  Nε-(carboxymethyl)lysine content of foods commonly consumed in a Western style diet , 2012 .

[17]  T. Imaizumi,et al.  Serum levels of advanced glycation end products (AGEs) are independent correlates of insulin resistance in nondiabetic subjects. , 2012, Cardiovascular therapeutics.

[18]  D. Maślińska,et al.  Immunodistribution of amyloid beta protein (Aβ) and advanced glycation end-product receptors (RAGE) in choroid plexus and ependyma of resuscitated patients. , 2011, Folia neuropathologica.

[19]  R. Ramasamy,et al.  Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications , 2011, Annals of the New York Academy of Sciences.

[20]  K. Clément,et al.  Dietary factors and low-grade inflammation in relation to overweight and obesity , 2011, British Journal of Nutrition.

[21]  Gong Zhang,et al.  Determination of advanced glycation endproducts by LC-MS/MS in raw and roasted almonds (Prunus dulcis). , 2011, Journal of agricultural and food chemistry.

[22]  I. Seiquer,et al.  Study of the urinary and faecal excretion of Nε-carboxymethyllysine in young human volunteers , 2011, Amino Acids.

[23]  H. Qian,et al.  Melanoidins produced by the Maillard reaction: Structure and biological activity , 2011 .

[24]  M. Knip,et al.  Advanced Glycation End Products Are Direct Modulators of β-Cell Function , 2011, Diabetes.

[25]  L. Ferrucci,et al.  Fat mass is inversely associated with serum carboxymethyl-lysine, an advanced glycation end product, in adults. , 2011, The Journal of nutrition.

[26]  S. Manna,et al.  Advanced Glycation End Products (AGEs) Induce Apoptosis via a Novel Pathway , 2011, The Journal of Biological Chemistry.

[27]  M. T. Luu,et al.  Glycation induction and antiglycation activity of skin care ingredients on living human skin explants , 2011, International journal of cosmetic science.

[28]  M. Sakaguchi,et al.  TIRAP, an Adaptor Protein for TLR2/4, Transduces a Signal from RAGE Phosphorylated upon Ligand Binding , 2011, PloS one.

[29]  J. Tang,et al.  Association of two glyoxalase I gene polymorphisms with nephropathy and retinopathy in Type 2 diabetes , 2011, Journal of endocrinological investigation.

[30]  Merlin C. Thomas,et al.  Targeted reduction of advanced glycation improves renal function in obesity. , 2011, Kidney international.

[31]  Gretchen A. Stevens,et al.  National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants , 2011, The Lancet.

[32]  K. Tan,et al.  Serum advanced glycation end products (AGEs) are associated with insulin resistance , 2011, Diabetes/metabolism research and reviews.

[33]  G. Striker,et al.  Restriction of Advanced Glycation End Products Improves Insulin Resistance in Human Type 2 Diabetes , 2011, Diabetes Care.

[34]  Y. Lee,et al.  Preventive effect of chlorogenic acid on lens opacity and cytotoxicity in human lens epithelial cells. , 2011, Biological & pharmaceutical bulletin.

[35]  G. Yen,et al.  Inhibition of advanced glycation endproduct formation by foodstuffs. , 2011, Food & function.

[36]  G. Striker,et al.  AGE restriction in diabetes mellitus: a paradigm shift , 2011, Nature Reviews Endocrinology.

[37]  M. Hellwig,et al.  Transport of Free and Peptide‐Bound Glycated Amino Acids: Synthesis, Transepithelial Flux at Caco‐2 Cell Monolayers, and Interaction with Apical Membrane Transport Proteins , 2011, Chembiochem : a European journal of chemical biology.

[38]  Y. Lee,et al.  Chlorogenic acid inhibits the formation of advanced glycation end products and associated protein cross-linking , 2011, Archives of pharmacal research.

[39]  A. Lampen,et al.  Toxicology and risk assessment of 5-Hydroxymethylfurfural in food. , 2011, Molecular nutrition & food research.

[40]  P. Jiang,et al.  Advanced glycation end-products induce heparanase expression in endothelial cells by the receptor for advanced glycation end products and through activation of the FOXO4 transcription factor , 2011, Molecular and Cellular Biochemistry.

[41]  Yong-de Peng,et al.  Glyoxalase I and aldose reductase gene polymorphisms and susceptibility to carotid atherosclerosis in type 2 diabetes. , 2011, Genetic testing and molecular biomarkers.

[42]  V. Tesar,et al.  Associations of Serum Levels of Advanced Glycation end Products with Nutrition Markers and Anemia in Patients with Chronic Kidney Disease , 2011, Renal failure.

[43]  C. Heizmann,et al.  Glycolaldehyde-modified β-lactoglobulin AGEs are unable to stimulate inflammatory signaling pathways in RAGE-expressing human cell lines. , 2011, Molecular nutrition & food research.

[44]  I. Mook‐Jung,et al.  RAGE: The beneficial and deleterious effects by diverse mechanisms of actions , 2011, Molecules and cells.

[45]  M. Glomb,et al.  Formation of arginine modifications in a model system of Nα-tert-butoxycarbonyl (Boc)-arginine with methylglyoxal. , 2011, Journal of agricultural and food chemistry.

[46]  I. Birlouez-Aragon,et al.  Health effects of dietary Maillard reaction products: the results of ICARE and other studies , 2010, Amino Acids.

[47]  V. Fogliano,et al.  Physiological relevance of dietary melanoidins , 2010, Amino Acids.

[48]  R. Morawicki,et al.  Enzymatic hydrolysis of poultry meal with endo- and exopeptidases. , 2010, Poultry science.

[49]  M. Hellwig,et al.  3-deoxygalactosone, a "new" 1,2-dicarbonyl compound in milk products. , 2010, Journal of agricultural and food chemistry.

[50]  Masayoshi Takeuchi,et al.  Pyridoxamine, an inhibitor of advanced glycation end product (AGE) formation ameliorates insulin resistance in obese, type 2 diabetic mice. , 2010, Protein and peptide letters.

[51]  Merlin C. Thomas,et al.  Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy. , 2010, Kidney international.

[52]  G. Striker,et al.  Advanced glycation end products in foods and a practical guide to their reduction in the diet. , 2010, Journal of the American Dietetic Association.

[53]  R. Ramasamy,et al.  Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging. , 2010, Biochemical pharmacology.

[54]  G. Cravotto,et al.  Microwave-assisted Maillard reactions for the preparation of advanced glycation end products (AGEs). , 2010, Organic & biomolecular chemistry.

[55]  T. Outeiro,et al.  The sour side of neurodegenerative disorders: the effects of protein glycation , 2010, The Journal of pathology.

[56]  J. Lecerf,et al.  A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases. , 2010, The American journal of clinical nutrition.

[57]  L. Sayre,et al.  A straightforward synthesis of pentosidine framework , 2010 .

[58]  V. Fogliano,et al.  Lipid oxidation promotes acrylamide formation in fat-rich model systems , 2010 .

[59]  Chien-Ning Huang,et al.  Association of dietary AGEs with circulating AGEs, glycated LDL, IL-1α and MCP-1 levels in type 2 diabetic patients , 2010, European journal of nutrition.

[60]  Merlin C. Thomas,et al.  Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy. , 2010, American journal of physiology. Renal physiology.

[61]  D. Cervantes-Laurean,et al.  Rutin metabolites: novel inhibitors of nonoxidative advanced glycation end products. , 2010, Free radical biology & medicine.

[62]  G. Striker,et al.  AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-delta: implications for vascular disease. , 2010, American journal of physiology. Cell physiology.

[63]  M. Hellwig,et al.  Transport of the advanced glycation end products alanylpyrraline and pyrralylalanine by the human proton-coupled peptide transporter hPEPT1. , 2010, Journal of agricultural and food chemistry.

[64]  I. Seiquer,et al.  Intake of Maillard reaction products reduces iron bioavailability in male adolescents. , 2009, Molecular nutrition & food research.

[65]  Tsukasa Suzuki,et al.  Positive association of serum levels of advanced glycation end products and high mobility group box-1 with asymmetric dimethylarginine in nondiabetic chronic kidney disease patients. , 2009, Metabolism: clinical and experimental.

[66]  L. Ferrucci,et al.  Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1. , 2009, The Journal of clinical endocrinology and metabolism.

[67]  M. Beckmann,et al.  A diet rich in Maillard reaction products protects LDL against copper induced oxidation ex vivo, a human intervention trial , 2009 .

[68]  E. Marceau,et al.  Profiling of alpha-dicarbonyl content of commercial honeys from different botanical origins: identification of 3,4-dideoxyglucoson-3-ene (3,4-DGE) and related compounds. , 2009, Journal of agricultural and food chemistry.

[69]  Kentaro Tsuji-Naito,et al.  Inhibitory effects of Chrysanthemum species extracts on formation of advanced glycation end products , 2009 .

[70]  G. Striker,et al.  Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia. , 2009, The American journal of pathology.

[71]  S. Ito,et al.  Methylglyoxal contributes to the development of insulin resistance and salt sensitivity in Sprague–Dawley rats , 2009, Journal of hypertension.

[72]  A. Heidland,et al.  Plasma advanced glycation end products are decreased in obese children compared with lean controls. , 2009, International journal of pediatric obesity : IJPO : an official journal of the International Association for the Study of Obesity.

[73]  Daisuke Koya,et al.  SIRT1 and insulin resistance , 2009, Nature Reviews Endocrinology.

[74]  M. Hellwig,et al.  Transport of free and peptide-bound pyrraline at intestinal and renal epithelial cells. , 2009, Journal of agricultural and food chemistry.

[75]  D. Ströhl,et al.  A Robust Synthesis of Nε-(Carboxymethyl)-L-lysine (CML) , 2009 .

[76]  T. Delatour,et al.  Analysis of advanced glycation endproducts in dairy products by isotope dilution liquid chromatography-electrospray tandem mass spectrometry. The particular case of carboxymethyllysine. , 2009, Journal of chromatography. A.

[77]  Qibin Zhang,et al.  A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease. , 2009, Journal of proteome research.

[78]  S. Yamagishi,et al.  Effects of high-AGE beverage on RAGE and VEGF expressions in the liver and kidneys , 2009, European journal of nutrition.

[79]  J. Ames,et al.  Determination of Nɛ-(carboxymethyl)lysine in food systems by ultra performance liquid chromatography-mass spectrometry , 2009, Amino Acids.

[80]  R. Hoffmann,et al.  Structural Basis for Pattern Recognition by the Receptor for Advanced Glycation End Products (RAGE)* , 2008, Journal of Biological Chemistry.

[81]  J. Ames Mass spectrometry to detect the site specificity of advanced glycation/lipoxidation end-product formation on protein: some challenges and solutions. , 2008, Biochemical Society transactions.

[82]  T. Koschinsky,et al.  Leptin decreases postprandially in people with type 2 diabetes, an effect reduced by the cooking method. , 2008, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[83]  Merlin C. Thomas,et al.  Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes , 2008, Diabetes.

[84]  Merlin C. Thomas,et al.  Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs. , 2008, American journal of physiology. Endocrinology and metabolism.

[85]  G. Striker,et al.  Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan. , 2008, The American journal of pathology.

[86]  T. Henle Maillard Reaction of Proteins and Advanced Glycation End Products (AGEs) in Food , 2008 .

[87]  Su-Yen Goh,et al.  The role of advanced glycation end products in progression and complications of diabetes , 2008 .

[88]  K. Herold,et al.  Receptor for Advanced Glycation End Products , 2008, Annals of the New York Academy of Sciences.

[89]  J. Ames Determination ofNɛ‐(Carboxymethyl)lysine in Foods and Related Systems , 2008, Annals of the New York Academy of Sciences.

[90]  T. Koschinsky,et al.  Dietary Advanced Glycation Endproducts and Oxidative Stress , 2008, Annals of the New York Academy of Sciences.

[91]  J. Lecerf,et al.  Strategy for the Study of the Health Impact of Dietary Maillard Products in Clinical Studies , 2008, Annals of the New York Academy of Sciences.

[92]  Chi-Tang Ho,et al.  Reactive dicarbonyl compounds and 5-(hydroxymethyl)-2-furfural in carbonated beverages containing high fructose corn syrup , 2008 .

[93]  C. Heizmann,et al.  N(epsilon)-carboxymethyllysine-modified proteins are unable to bind to RAGE and activate an inflammatory response. , 2008, Molecular nutrition & food research.

[94]  T. Imaizumi,et al.  Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein‐1 (MCP‐1) levels in patients with type 2 diabetes , 2008, Diabetes/metabolism research and reviews.

[95]  M. Nakhjavani,et al.  Effect of spermine on lipid profile and HDL functionality in the streptozotocin-induced diabetic rat model. , 2008, Life sciences.

[96]  R. Ramasamy,et al.  Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice. , 2008, The Journal of clinical investigation.

[97]  W. R. Bruce,et al.  Marginal thiamine deficiency increases oxidative markers in the plasma and selected tissues in F344 rats , 2007 .

[98]  Mark E. Williams,et al.  Effects of Pyridoxamine in Combined Phase 2 Studies of Patients with Type 1 and Type 2 Diabetes and Overt Nephropathy , 2007, American Journal of Nephrology.

[99]  J. Ames Evidence against dietary advanced glycation endproducts being a risk to human health. , 2007, Molecular nutrition & food research.

[100]  T. Henle Dietary advanced glycation end products--a risk to human health? A call for an interdisciplinary debate. , 2007, Molecular nutrition & food research.

[101]  K. Šebeková,et al.  Dietary advanced glycation endproducts (AGEs) and their health effects--PRO. , 2007, Molecular nutrition & food research.

[102]  R. Ramasamy,et al.  Arguing for the motion: yes, RAGE is a receptor for advanced glycation endproducts. , 2007, Molecular nutrition & food research.

[103]  Paul J Thornalley Dietary AGEs and ALEs and risk to human health by their interaction with the receptor for advanced glycation endproducts (RAGE)--an introduction. , 2007, Molecular nutrition & food research.

[104]  C. Heizmann The mechanism by which dietary AGEs are a risk to human health is via their interaction with RAGE: arguing against the motion. , 2007, Molecular nutrition & food research.

[105]  V. Gökmen,et al.  Effects of some cations on the formation of acrylamide and furfurals in glucose–asparagine model system , 2007 .

[106]  B. Stratmann,et al.  Adiponectin Decreases Postprandially Following a Heat-Processed Meal in Individuals With Type 2 Diabetes , 2007, Diabetes Care.

[107]  G. Striker,et al.  Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet: association with increased AGER1 expression. , 2007, The American journal of pathology.

[108]  M. Laakso,et al.  Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up study , 2007, Diabetologia.

[109]  F. Hou,et al.  Restricted intake of dietary advanced glycation end products retards renal progression in the remnant kidney model. , 2007, Kidney international.

[110]  Bernd Stratmann,et al.  Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. , 2007, The American journal of clinical nutrition.

[111]  Manuel Dornier,et al.  Thermal degradation of antioxidant micronutrients in citrus juice: kinetics and newly formed compounds. , 2007, Journal of agricultural and food chemistry.

[112]  L. Ferrucci,et al.  Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.

[113]  V. Somoza,et al.  Forty years of furosine - forty years of using Maillard reaction products as indicators of the nutritional quality of foods. , 2007, Molecular nutrition & food research.

[114]  I. Seiquer,et al.  Maillard reaction indicators in diets usually consumed by adolescent population. , 2007, Molecular nutrition & food research.

[115]  I. Birlouez-Aragon,et al.  Evaluation of a gas chromatography/mass spectrometry method for the quantification of carboxymethyllysine in food samples. , 2007, Journal of chromatography. A.

[116]  Parvez Hossain,et al.  Obesity and diabetes in the developing world--a growing challenge. , 2007, The New England journal of medicine.

[117]  C. Nguyen Toxicity of the AGEs generated from the Maillard reaction: On the relationship of food‐AGEs and biological‐AGEs , 2006 .

[118]  C. Murray,et al.  Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment , 2006, The Lancet.

[119]  Jens Pietzsch,et al.  Biodistribution and catabolism of 18F-labeled N-ε-fructoselysine as a model of Amadori products , 2006 .

[120]  L. Hunsicker,et al.  The Advanced Glycation End Product Nε-Carboxymethyllysine Is Not a Predictor of Cardiovascular Events and Renal Outcomes in Patients With Type 2 Diabetic Kidney Disease and Hypertension , 2006 .

[121]  J. He,et al.  Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor , 2006, Proceedings of the National Academy of Sciences.

[122]  V. Somoza,et al.  Dose-dependent utilisation of casein-linked lysinoalanine, N(epsilon)-fructoselysine and N(epsilon)-carboxymethyllysine in rats. , 2006, Molecular nutrition & food research.

[123]  M. Murkovic,et al.  Analysis of 5-hydroxymethylfurfual in coffee, dried fruits and urine. , 2006, Molecular nutrition & food research.

[124]  J. Silvan,et al.  Analysis and biological properties of amino acid derivates formed by Maillard reaction in foods. , 2006, Journal of pharmaceutical and biomedical analysis.

[125]  Michael J. Pencina,et al.  Trends in the Incidence of Type 2 Diabetes Mellitus From the 1970s to the 1990s: The Framingham Heart Study , 2006, Circulation.

[126]  M. Brandsch,et al.  Transepithelial flux of early and advanced glycation compounds across Caco-2 cell monolayers and their interaction with intestinal amino acid and peptide transport systems. , 2006, The British journal of nutrition.

[127]  I. Seiquer,et al.  Diets rich in Maillard reaction products affect protein digestibility in adolescent males aged 11-14 y. , 2006, The American journal of clinical nutrition.

[128]  J. Schneider,et al.  Postprandial mononuclear NF-kappaB activation is independent of the AGE-content of a single meal. , 2006, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[129]  M. Zeier,et al.  An oral load of the early glycation compound lactuloselysine fails to accumulate in the serum of uraemic patients. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[130]  F. Fenaille,et al.  Synthesis, tandem MS- and NMR-based characterization, and quantification of the carbon 13-labeled advanced glycation endproduct, 6-N-carboxymethyllysine , 2006, Amino Acids.

[131]  M. Engelse,et al.  Interaction of Nepsilon(carboxymethyl)lysine- and methylglyoxal-modified albumin with endothelial cells and macrophages. Splice variants of RAGE may limit the responsiveness of human endothelial cells to AGEs. , 2006, Thrombosis and haemostasis.

[132]  Paul J Thornalley Measurement of Protein Glycation, Glycated Peptides, and Glycation Free Adducts , 2005, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[133]  W. R. Bruce,et al.  The effects of partial thiamin deficiency and oxidative stress (i.e., glyoxal and methylglyoxal) on the levels of α‐oxoaldehyde plasma protein adducts in Fischer 344 rats , 2005, FEBS letters.

[134]  P. Gruber,et al.  Chemoselective synthesis of peptides containing major advanced glycation end-products of lysine and arginine. , 2005, The journal of peptide research : official journal of the American Peptide Society.

[135]  J. Uribarri,et al.  Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake. , 2005, Diabetes.

[136]  T. Henle Protein-bound advanced glycation endproducts (AGEs) as bioactive amino acid derivatives in foods , 2005, Amino Acids.

[137]  Veronika Somoza,et al.  Five years of research on health risks and benefits of Maillard reaction products: an update. , 2005, Molecular nutrition & food research.

[138]  Paul J Thornalley,et al.  Assay of advanced glycation endproducts in selected beverages and food by liquid chromatography with tandem mass spectrometric detection. , 2005, Molecular nutrition & food research.

[139]  M. N. Ramesh,et al.  Thermal degradation kinetics of nutrients in orange juice heated by electromagnetic and conventional methods , 2005 .

[140]  Volker Böhm,et al.  Processing strawberries to different products alters contents of vitamin C, total phenolics, total anthocyanins, and antioxidant capacity. , 2005, Journal of agricultural and food chemistry.

[141]  A. Heidland,et al.  Dietary Bread Crust Advanced Glycation End Products Bind to the Receptor for AGEs in HEK‐293 Kidney Cells but Are Rapidly Excreted after Oral Administration to Healthy and Subtotally Nephrectomized Rats , 2005, Annals of the New York Academy of Sciences.

[142]  T. Henle,et al.  Studies on Absorption and Elimination of Dietary Maillard Reaction Products , 2005, Annals of the New York Academy of Sciences.

[143]  J. Uribarri,et al.  Diet‐Derived Advanced Glycation End Products Are Major Contributors to the Body's AGE Pool and Induce Inflammation in Healthy Subjects , 2005, Annals of the New York Academy of Sciences.

[144]  A. Smit,et al.  Simple Noninvasive Measurement of Skin Autofluorescence , 2005, Annals of the New York Academy of Sciences.

[145]  V. Yaylayan,et al.  Oxidative Pyrolysis and Postpyrolytic Derivatization Techniques for the Total Analysis of Maillard Model Systems: Investigation of Control Parameters of Maillard Reaction Pathways , 2005, Annals of the New York Academy of Sciences.

[146]  F. Hidalgo,et al.  Interplay between the Maillard Reaction and Lipid Peroxidation in Biochemical Systems , 2005, Annals of the New York Academy of Sciences.

[147]  P. Boor,et al.  Renal Effects of Oral Maillard Reaction Product Load in the Form of Bread Crusts in Healthy and Subtotally Nephrectomized Rats , 2005, Annals of the New York Academy of Sciences.

[148]  P. Beisswenger,et al.  Ketosis Leads to Increased Methylglyoxal Production on the Atkins Diet , 2005, Annals of the New York Academy of Sciences.

[149]  N. V. Chuyen,et al.  Are Food Advanced Glycation End Products Toxic in Biological Systems? , 2005, Annals of the New York Academy of Sciences.

[150]  H. Nursten The Maillard Reaction: Chemistry, Biochemistry and Implications , 2005 .

[151]  B. Hudson,et al.  Pyridoxamine as a multifunctional pharmaceutical: targeting pathogenic glycation and oxidative damage , 2005, Cellular and Molecular Life Sciences CMLS.

[152]  P. Finot The absorption and metabolism of modified amino acids in processed foods. , 2005, Journal of AOAC International.

[153]  J. Hwang,et al.  Clinical implications of Nε‐(carboxymethyl)lysine, advanced glycation end product, in children and adolescents with type 1 diabetes , 2005, Diabetes, obesity & metabolism.

[154]  M. Laakso,et al.  High Serum Levels of Advanced Glycation End Products Predict Increased Coronary Heart Disease Mortality in Nondiabetic Women but not in Nondiabetic Men: A Population-Based 18-Year Follow-Up Study , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[155]  Neil Mann,et al.  Origins and evolution of the Western diet: health implications for the 21st century. , 2005, The American journal of clinical nutrition.

[156]  C. Cordeiro,et al.  Argpyrimidine, a methylglyoxal-derived advanced glycation end-product in familial amyloidotic polyneuropathy. , 2005, The Biochemical journal.

[157]  F. Hidalgo,et al.  Coordinate Contribution of Lipid Oxidation and Maillard Reaction to the Nonenzymatic Food Browning , 2005, Critical reviews in food science and nutrition.

[158]  S. Horiuchi,et al.  Conventional antibody against Nε-(carboxymethyl)lysine (CML) shows cross-reaction to Nε-(carboxyethyl)lysine (CEL): Immunochemical quantification of CML with a specific antibody , 2004 .

[159]  A. Smit,et al.  The clinical relevance of advanced glycation endproducts (AGE) and recent developments in pharmaceutics to reduce AGE accumulation. , 2004, Current medicinal chemistry.

[160]  J. He,et al.  Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[161]  J. Uribarri,et al.  Advanced glycoxidation end products in commonly consumed foods. , 2004, Journal of the American Dietetic Association.

[162]  J. Uribarri,et al.  Glycoxidation and Diabetic Complications: Modern Lessons and a Warning? , 2004, Reviews in Endocrine and Metabolic Disorders.

[163]  J. Uribarri,et al.  High Levels of Dietary Advanced Glycation End Products Transform Low-Dersity Lipoprotein Into a Potent Redox-Sensitive Mitogen-Activated Protein Kinase Stimulant in Diabetic Patients , 2004, Circulation.

[164]  U. Ott,et al.  Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein. , 2004, Kidney international.

[165]  J. Rufián‐Henares,et al.  Pyrraline content in enteral formula processing and storage and model systems , 2004 .

[166]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[167]  D. Kass,et al.  Advanced glycation end product cross-linking: pathophysiologic role and therapeutic target in cardiovascular disease. , 2004, Congestive heart failure.

[168]  C. Dinarello,et al.  Effect of advanced glycation end products on endotoxin-induced TNF-alpha, IL-1beta and IL-8 in human peripheral blood mononuclear cells. , 2004, Clinical nephrology.

[169]  T. Hughes,et al.  Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products , 2004, Diabetologia.

[170]  J. Uribarri,et al.  Glycoxidation and inflammation in renal failure patients. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[171]  A. Tritscher Human health risk assessment of processing-related compounds in food. , 2004, Toxicology letters.

[172]  T. Sugimura,et al.  Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish , 2004, Cancer science.

[173]  J. Buchert,et al.  Industrial Enzymes: Enzymes in Nonfood Applications , 2004 .

[174]  M. Peppa,et al.  Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice. , 2003, Diabetes.

[175]  Anne Dawnay,et al.  Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. , 2003, The Biochemical journal.

[176]  Paul J Thornalley Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. , 2003, Archives of biochemistry and biophysics.

[177]  T. Miyata,et al.  Advanced glycation end products in uremia. , 2003, Advances in renal replacement therapy.

[178]  J. Uribarri,et al.  Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[179]  M. Peppa,et al.  Fetal or neonatal low-glycotoxin environment prevents autoimmune diabetes in NOD mice. , 2003, Diabetes.

[180]  E. Fisher,et al.  Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice. , 2003, Atherosclerosis.

[181]  T. Henle AGEs in foods: do they play a role in uremia? , 2003, Kidney international. Supplement.

[182]  A. Heidland,et al.  Effects of a diet rich in advanced glycation end products in the rat remnant kidney model. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[183]  J. Uribarri,et al.  Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients. , 2003, Journal of the American Society of Nephrology : JASN.

[184]  T. Henle,et al.  Studies on the formation of furosine and pyridosine during acid hydrolysis of different Amadori products of lysine , 2003 .

[185]  M. Huijberts,et al.  N(carboxymethyl)lysine as a biomarker for microvascular complications in type 2 diabetic patients. , 2003, Diabetes & metabolism.

[186]  G. P. Rizzi Free Radicals in the Maillard Reaction , 2003 .

[187]  T. Hofmann,et al.  RAGE-mediated MAPK activation by food-derived AGE and non-AGE products. , 2003, Biochemical and biophysical research communications.

[188]  T. Kislinger,et al.  RAGE Blockade Stabilizes Established Atherosclerosis in Diabetic Apolipoprotein E–Null Mice , 2002, Circulation.

[189]  M. Peppa,et al.  Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[190]  Monica Anese,et al.  Chemical characterization and antioxidant properties of coffee melanoidins. , 2002, Journal of agricultural and food chemistry.

[191]  E. Fisher,et al.  Lowering of dietary advanced glycation endproducts (AGE) reduces neointimal formation after arterial injury in genetically hypercholesterolemic mice. , 2002, Atherosclerosis.

[192]  Eden Tareke,et al.  Analysis of acrylamide, a carcinogen formed in heated foodstuffs. , 2002, Journal of agricultural and food chemistry.

[193]  C. Wanner,et al.  Advanced glycation end products and mortality in hemodialysis patients. , 2002, Kidney international.

[194]  E. Fisher,et al.  Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. , 2002, Diabetes.

[195]  M. Peppa,et al.  Oxidative Stress-Inducing Carbonyl Compounds From Common Foods: Novel Mediators of Cellular Dysfunction , 2002, Molecular medicine.

[196]  R. Bucala,et al.  Advanced glycation end products and endothelial dysfunction in type 2 diabetes. , 2002, Diabetes care.

[197]  Paul J Thornalley,et al.  Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and application to Nepsilon-carboxymethyl-lysine- and Nepsilon-(1-carboxyethyl)lysine-modified albumin. , 2002, The Biochemical journal.

[198]  M. Steffes,et al.  Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products , 2002, Diabetes/metabolism research and reviews.

[199]  Q. Beg,et al.  Bacterial alkaline proteases: molecular approaches and industrial applications , 2002, Applied Microbiology and Biotechnology.

[200]  H. Erbersdobler,et al.  Effect of Heat-Treated Proteins on Selected Parameters of the Biotransformation System in the Rat , 2002, Annals of Nutrition and Metabolism.

[201]  P. Schieberle,et al.  Chemical interactions between odor-active thiols and melanoidins involved in the aroma staling of coffee beverages. , 2002, Journal of agricultural and food chemistry.

[202]  A. Heidland,et al.  Enhanced plasma levels of advanced glycation end products (AGE) and pro-inflammatory cytokines in children/adolescents with chronic renal insufficiency and after renal replacement therapy by dialysis and transplantation--are they inter-related? , 2001, Clinical nephrology.

[203]  A. Heidland,et al.  Plasma levels of advanced glycation end products in healthy, long-term vegetarians and subjects on a western mixed diet , 2001, European journal of nutrition.

[204]  R. Günther,et al.  RAGE expression and AGE-induced MAP kinase activation in Caco-2 cells. , 2001, Biochemical and biophysical research communications.

[205]  M. Glomb,et al.  Amides Are Novel Protein Modifications Formed by Physiological Sugars* , 2001, The Journal of Biological Chemistry.

[206]  J. Nagy,et al.  N(epsilon)-(carboxymethyl)lysine levels in patients with type 2 diabetes: role of renal function. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[207]  M. Crow,et al.  Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion. , 2001, Diabetes.

[208]  H. Erbersdobler,et al.  Metabolic transit of Amadori products. , 2001, Die Nahrung.

[209]  M. Scheunemann,et al.  Radio fluorination and positron emission tomography (PET) as a new approach to study the in vivo distribution and elimination of the advanced glycation endproducts Nε-carboxymethyllysine (CML) and nε-carboxyethyllysine (CEL) , 2001 .

[210]  H. Bühler,et al.  Identification and quantitative evaluation of the lysine-arginine crosslinks GODIC, MODIC, DODIC, and glucosepan in foods. , 2001, Die Nahrung.

[211]  F. Yokokawa,et al.  An expeditious synthesis of pentosidine, an advanced glycation end product , 2001 .

[212]  A. Schmidt,et al.  Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. , 2001, American journal of physiology. Endocrinology and metabolism.

[213]  P. Schieberle,et al.  Model studies on the influence of coffee melanoidins on flavor volatiles of coffee beverages. , 2001, Journal of agricultural and food chemistry.

[214]  W. Hung,et al.  Role of receptor for advanced glycation end‐product (RAGE) and the JAK/STAT‐signaling pathway in AGE‐induced collagen production in NRK‐49F cells , 2001, Journal of cellular biochemistry.

[215]  T. Koschinsky,et al.  Presence of Diabetic Complications in Type 1 Diabetic Patients Correlates with Low Expression of Mononuclear Cell AGE-Receptor-1 and Elevated Serum AGE , 2001, Molecular medicine.

[216]  H. Erbersdobler,et al.  Metabolic Transit and in vivo Effects of Melanoidins and Precursor Compounds Deriving from the Maillard Reaction , 2001, Annals of Nutrition and Metabolism.

[217]  A. Schmidt,et al.  The biology of the receptor for advanced glycation end products and its ligands. , 2000, Biochimica et biophysica acta.

[218]  Alan W. Stitt,et al.  Differential expression of renal AGE-receptor genes in NOD mice: possible role in nonobese diabetic renal disease. , 2000, Kidney international.

[219]  J. Schlatter,et al.  5-Hydroxymethylfurfural: assessment of mutagenicity, DNA-damaging potential and reactivity towards cellular glutathione. , 2000, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[220]  P. Schieberle,et al.  Quantitative model studies on the formation of aroma-active aldehydes and acids by strecker-type reactions. , 2000, Journal of agricultural and food chemistry.

[221]  Paul J Thornalley,et al.  Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. , 1999, The Biochemical journal.

[222]  R. Klaiber,et al.  Cross-linking of proteins by Maillard processes: characterization and detection of lysine-arginine cross-links derived from glyoxal and methylglyoxal. , 1999, Bioorganic & medicinal chemistry.

[223]  T. Kislinger,et al.  N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression* , 1999, The Journal of Biological Chemistry.

[224]  N. Ankrah,et al.  Toxicity of low levels of methylglyoxal: depletion of blood glutathione and adverse effect on glucose tolerance in mice. , 1999, Toxicology letters.

[225]  K. Birkeland,et al.  Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease. , 1999, Diabetes care.

[226]  B. Wedzicha,et al.  Nonenzymatic browning reactions of retro-aldol degradation products of carbohydrates , 1999 .

[227]  H. Huttunen,et al.  Receptor for Advanced Glycation End Products (RAGE)-mediated Neurite Outgrowth and Activation of NF-κB Require the Cytoplasmic Domain of the Receptor but Different Downstream Signaling Pathways* , 1999, The Journal of Biological Chemistry.

[228]  H. Vlassara,et al.  Dietary glycotoxins: inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration. , 1999, Diabetes.

[229]  S. Drusch,et al.  Determination of Nϵ-carboxymethyllysine in milk products by a modified reversed-phase HPLC method , 1999 .

[230]  F. Cuccurullo,et al.  Advanced glycation end products in children and adolescents with diabetes: relation to glycemic control and early microvascular complications. , 1999, The Journal of pediatrics.

[231]  A. Schmidt,et al.  Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. , 1999, Circulation research.

[232]  T. Florea,et al.  Evaluation of radical products from beta-alanine/sugar mixtures by use of GC-MS with the galvinoxyl radical. , 1999, Journal of agricultural and food chemistry.

[233]  T. Hofmann,et al.  Studies on radical intermediates in the early stage of the nonenzymatic browning reaction of carbohydrates and amino acids. , 1999, Journal of agricultural and food chemistry.

[234]  M. Fountoulakis,et al.  Hydrolysis and amino acid composition analysis of proteins , 1998 .

[235]  Paul J Thornalley Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs. , 1998, Cellular and molecular biology.

[236]  J. Clausen,et al.  The advanced glycation end product Nepsilon-(carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes. , 1998, Diabetes care.

[237]  T. Hofmann AcetylformoinA Chemical Switch in the Formation of Colored Maillard Reaction Products from Hexoses and Primary and Secondary Amino Acids , 1998 .

[238]  T. Hofmann Studies on the relationship between molecular weight and the color potency of fractions obtained by thermal treatment of glucose/amino acid and glucose/protein solutions by using ultracentrifugation and color dilution techniques , 1998 .

[239]  M. Jägerstad,et al.  Carcinogenic heterocyclic amines in model systems and cooked foods: a review on formation, occurrence and intake. , 1998, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[240]  H. King,et al.  Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections , 1998, Diabetes Care.

[241]  H. Hoeger,et al.  Oral administration of methylglyoxal leads to kidney collagen accumulation in the mouse. , 1998, Life sciences.

[242]  L. Kroh,et al.  Formation of α-dicarbonyl fragments from mono- and disaccharides under caramelization and Maillard reaction conditions , 1998 .

[243]  G. Wondrak,et al.  Pentoses and Hexoses as Sources of New Melanoidin-like Maillard Polymers , 1998 .

[244]  M. Nangaku,et al.  Renal catabolism of advanced glycation end products: the fate of pentosidine. , 1998, Kidney international.

[245]  A. Amos,et al.  The Rising Global Burden of Diabetes and its Complications: Estimates and Projections to the Year 2010 , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[246]  H. Vlassara,et al.  Standardizing the immunological measurement of advanced glycation endproducts using normal human serum. , 1997, Journal of immunological methods.

[247]  A. Schmidt,et al.  Activation of the Receptor for Advanced Glycation End Products Triggers a p21 ras -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress* , 1997, The Journal of Biological Chemistry.

[248]  R. Bucala,et al.  Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[249]  J. Baynes,et al.  N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. , 1997, The Biochemical journal.

[250]  T. J. Berg,et al.  Increased Serum Levels of Advanced Glycation End Products (AGEs) in Children and Adolescents With IDDM , 1997, Diabetes Care.

[251]  D. Sell Ageing promotes the increase of early glycation Amadori product as assessed by ϵ-N-(2-furoylmethyl)-l-lysine (furosine) levels in rodent skin collagen The relationship to dietary restriction and glycoxidation , 1997, Mechanisms of Ageing and Development.

[252]  H. Klostermeyer,et al.  Detection and quantification of pentosidine in foods , 1997 .

[253]  Alan W. Stitt,et al.  Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[254]  B. Caemmerer,et al.  Investigation of the contribution of radicals to the mechanism of the early stage of the Maillard reaction , 1996 .

[255]  J. V. Hunt,et al.  Effect of flavones on glucose-induced changes in human serum albumen. , 1996, Biochemical Society transactions.

[256]  R. Bucala,et al.  Novel modifications of N a-boc-arginine and N a-CBZ-lysine by methylglyoxal , 1996 .

[257]  T. Lyons,et al.  The Advanced Glycation End Product, N-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation Reactions (*) , 1996, The Journal of Biological Chemistry.

[258]  P. B. Chock,et al.  Free Radicals Generated during the Glycation Reaction of Amino Acids by Methylglyoxal , 1995, The Journal of Biological Chemistry.

[259]  V. Monnier,et al.  Mechanism of Protein Modification by Glyoxal and Glycolaldehyde, Reactive Intermediates of the Maillard Reaction (*) , 1995, The Journal of Biological Chemistry.

[260]  J. Baynes,et al.  Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. , 1995, Biochemistry.

[261]  A. Schmidt,et al.  Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[262]  H. Klostermeyer,et al.  Detection and identification of a protein-bound imidazolone resulting from the reaction of arginine residues and methylglyoxal , 1994 .

[263]  H. Erbersdobler,et al.  Determination of Nε -carboxymethyllysine by a reversed-phase high-performance liquid chromatography method , 1994 .

[264]  H. E. Berg,et al.  Degradation of lactose during heating of milk. 1. Reaction pathways , 1994 .

[265]  Y. Zou,et al.  Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. , 1993, The American journal of pathology.

[266]  R. Bucala,et al.  Lipid advanced glycosylation: pathway for lipid oxidation in vivo. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[267]  T. Shibamoto,et al.  Gas chromatographic analysis of glyoxal and methylglyoxal formed from lipids and related compounds upon ultraviolet irradiation , 1993 .

[268]  M. Brownlee,et al.  Glycation Products and the Pathogenesis of Diabetic Complications , 1992, Diabetes Care.

[269]  K. O. Elliston,et al.  Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. , 1992, The Journal of biological chemistry.

[270]  R. Bucala,et al.  Immunochemical detection of advanced glycosylation end products in vivo. , 1992, The Journal of biological chemistry.

[271]  E. Friedman,et al.  Advanced glycosylation end products in patients with diabetic nephropathy. , 1991, The New England journal of medicine.

[272]  M. Suthanthiran,et al.  Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins , 1991, The Journal of experimental medicine.

[273]  H. Klostermeyer,et al.  Evaluation of the extent of the early Maillard-reaction in milk products by direct measurement of the Amadori-product lactuloselysine , 1991, Zeitschrift fur Lebensmittel-Untersuchung und -Forschung.

[274]  E. Schleicher,et al.  New Aspects of the Maillard Reaction in Foods and in the Human Body , 1990 .

[275]  R. Dean,et al.  Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. , 1988, The Biochemical journal.

[276]  P. Finot,et al.  Identification of N.epsilon.-carboxymethyllysine: a new Maillard reaction product in rat urine , 1987 .

[277]  H. Vlassara,et al.  Novel macrophage receptor for glucose-modified proteins is distinct from previously described scavenger receptors , 1986, The Journal of experimental medicine.

[278]  M. Namiki,et al.  Role of Sugar Fragmentation in an Early Stage Browning of Amino-carbonyl Reaction of Sugar with Amino Acid , 1986 .

[279]  J. Baynes,et al.  Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. , 1986, The Journal of biological chemistry.

[280]  A. Cerami,et al.  High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[281]  Paul J Thornalley,et al.  The autoxidation of glyceraldehyde and other simple monosaccharides , 1984, Experientia.

[282]  M. Namiki,et al.  A New Mechanism of the Maillard Reaction Involving Sugar Fragmentation and Free Radical Formation , 1983 .

[283]  M. Namiki,et al.  Formation of Two-Carbon Sugar Fragment at an Early Stage of the Browning Reaction of Sugar with Amine , 1980 .

[284]  F. Hayase,et al.  Formation of .EPSILON.-(2-formyl-5-hydroxymethyl-pyrrol-1-yl)-L-norleucine in the maillard reaction between D-glucose and L-lysine. , 1980 .

[285]  J. Baynes,et al.  Nonenzymatically glucosylated albumin. In vitro preparation and isolation from normal human serum. , 1979, The Journal of biological chemistry.

[286]  Y. Ohta,et al.  Electron spin resonance spectral study on the structure of the novel free radical products formed by the reactions of sugars with amino acids or amines. , 1977, Journal of agricultural and food chemistry.

[287]  H. Zahn,et al.  Zum Vorkommen von Isopeptidbindungen in erhitztem Milcheiweiß , 1976 .

[288]  M. Namiki,et al.  Development of novel free radicals during the amino-carbonyl reaction of sugars with amino acids , 1975 .

[289]  C. Chichester,et al.  Nutritional consequences of the Maillard reaction. Amino acid availability from fructose-leucine and fructose-tryptophan in the rat. , 1973, The Journal of nutrition.

[290]  O. Blumenfeld,et al.  Studies of an unusual hemoglobin in patients with diabetes mellitus. , 1969, Biochemical and biophysical research communications.

[291]  E. A. Day,et al.  Further observations on the dicarbonyl compounds formed via autoxidation of methyl linoleate , 1965, Journal of the American Oil Chemists' Society.

[292]  J. Hodge Dehydrated Foods, Chemistry of Browning Reactions in Model Systems , 1953 .

[293]  I. Seiquer,et al.  Increased Maillard reaction products intake reduces phosphorus digestibility in male adolescents. , 2011, Nutrition.

[294]  V. Yaylayan,et al.  The Maillard reaction and food quality deterioration. , 2010 .

[295]  D. Noto,et al.  A novel component of the metabolic syndrome: the oxidative stress. , 2010, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[296]  G. Striker,et al.  AGE-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of p66shc-dependent FKHRL1 phosphorylation. , 2008, American journal of physiology. Cell physiology.

[297]  Nessar Ahmed,et al.  Advanced glycation endproducts--role in pathology of diabetic complications. , 2005, Diabetes research and clinical practice.

[298]  H. Klostermeyer,et al.  Protein-Bound Maillard Compounds in Foods: Analytical and Technological Aspects , 2005 .

[299]  R. Bucala,et al.  Association between acute-phase reactants and advanced glycation end products in type 2 diabetes. , 2004, Diabetes care.

[300]  T. Opitz,et al.  Studies on the occurrence and formation of 1,2-dicarbonyls in honey , 2004 .

[301]  Hiroshi Yamamoto,et al.  Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes. , 2003, Journal of diabetes and its complications.

[302]  Grace S. L. Lee,et al.  End-stage renal disease in the Asian-Pacific region. , 2003, Seminars in nephrology.

[303]  R. Schinzel,et al.  Advanced glycation end products and nutrition. , 2002, Physiological research.

[304]  R. Nagaraj,et al.  N(delta)-(5-hydroxy-4,6-dimethylpyrimidine-2-yl)-l-ornithine, a novel methylglyoxal-arginine modification in beer. , 2001, Journal of agricultural and food chemistry.

[305]  Y. Aso,et al.  Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes , 2000, Acta Diabetologica.

[306]  Paul J Thornalley THE CLINICAL SIGNIFICANCE OF GLYCATION , 1999 .

[307]  J. Baynes,et al.  Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. , 1999, Diabetes.

[308]  S. Vasdev,et al.  Aldehyde induced hypertension in rats: prevention by N-acetyl cysteine. , 1998, Artery.

[309]  P. Riederer,et al.  Determination of Advanced Glycation End Products in Serum by Fluorescence Spectroscopy and Competitive ELISA , 1997, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[310]  T. Henle,et al.  Synthesis of pyrraline reference material , 1996, Zeitschrift fur Lebensmittel-Untersuchung und -Forschung.

[311]  M. Brownlee,et al.  Advanced protein glycosylation in diabetes and aging. , 1995, Annual review of medicine.

[312]  M. Friedman,et al.  Dietary impact of food processing. , 1992, Annual review of nutrition.

[313]  R. Bucala,et al.  Advanced glycosylation: chemistry, biology, and implications for diabetes and aging. , 1992, Advances in pharmacology.

[314]  P. Morrissey,et al.  Nutritional and toxicological aspects of the Maillard browning reaction in foods. , 1989, Critical reviews in food science and nutrition.

[315]  J. Baynes,et al.  [8] Nonenzymatic glucosylation of lysine residues in albumin , 1984 .

[316]  P. Finot,et al.  Metabolic transit of early and advanced Maillard products. , 1981, Progress in food & nutrition science.

[317]  H. Kato Estimation of melanoidin structure by pyrolysis and oxidation. , 1981 .

[318]  S. Kusumoto,et al.  Nε-(carboxymethyl)-l-lysine in the acid hydrolysate of Sagittaria pygmaea , 1979 .

[319]  R. Pethig,et al.  Electronic properties of the casein-methylglyoxal complex. , 1977, Proceedings of the National Academy of Sciences of the United States of America.